News
Absci and AstraZeneca to advance AI-driven oncology candidate
Absci Corporation is collaborating with AstraZeneca to deliver an AI-designed antibody against an oncology target.
The collaboration combines Absci’s Integrated Drug Creation platform with AstraZeneca’s...
Cancer Research UK and Guardant Health collaborate to advance cancer research and clinical development...
Cancer Research UK, one of the world’s largest charitable funders of cancer research, its innovation unit, Cancer Research Horizons, and Guardant Health, a precision...
AQEMIA forms $140m multi-year collaboration with Sanofi
AQEMIA, a pharmatech company leveraging AI and quantum-inspired physics to accelerate the discovery of small molecule drug candidates with higher probability of success in...
